These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30155248)

  • 21. Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.
    Yu CG; Jiang XY; Li B; Gan L; Huang JF
    Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of myometrial invasion in endometrial carcinoma].
    Peng P; Shen K; Lang J; Huang H; Wu M; Cui Q; Jiang Y; Tan L
    Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):679-82. PubMed ID: 12487925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs MR imaging.
    DelMaschio A; Vanzulli A; Sironi S; Spagnolo D; Belloni C; Garancini P; Taccagni GL
    AJR Am J Roentgenol; 1993 Mar; 160(3):533-8. PubMed ID: 8430547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
    Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
    Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase-2 and p53 expressions in endometrial cancer.
    Jeon YT; Kang S; Kang DH; Yoo KY; Park IA; Bang YJ; Kim JW; Park NH; Kang SB; Lee HP; Song YS
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1538-42. PubMed ID: 15342458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer.
    Ayhan A; Şahin H; Sari ME; Yalçin I; Haberal A; Meydanli MM
    Int J Gynecol Cancer; 2019 Mar; 29(3):505-512. PubMed ID: 30665899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of magnetic resonance imaging in preoperative staging of endometrial carcinoma according to International Federation of Gynecology and Obstetrics (2009) staging criteria].
    Du L; Lei Y; Li D; Qiu X; Liang B
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1048-51. PubMed ID: 22820597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A correlation between the expression of estrogen receptors and progesterone receptors in cancer cells and in the myometrium and prognostic factors in endometrial cancer.
    Tomica D; Ramić S; Danolić D; Knezević F; Kolak T; Balja MP; Alvir I; Mamić I; Puljiz M
    Coll Antropol; 2014 Mar; 38(1):129-34. PubMed ID: 24851606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Predictors of recurrence and prognosis in patients with stage I and II endometrial carcinoma].
    Li M; Wang Z; Zhao L; Li X; Wang J; Zhang C; Wei L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):455-9. PubMed ID: 25169640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification.
    Karnezis AN; Leung S; Magrill J; McConechy MK; Yang W; Chow C; Kobel M; Lee CH; Huntsman DG; Talhouk A; Kommoss F; Gilks CB; McAlpine JN
    J Pathol Clin Res; 2017 Oct; 3(4):279-293. PubMed ID: 29085668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53, estrogen and progesterone receptors in diagnostic curettage for endometrial adenocarcinoma and their correlation with morphological data and disease stage at hysterectomy.
    Bonfitto VL; de Angelo Andrade LA
    Sao Paulo Med J; 2003 Jul; 121(4):163-6. PubMed ID: 14595509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
    Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
    Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncocytic metaplasia and carcinoma of the endometrium: an immunohistochemical and ultrastructural study.
    Silver SA; Cheung AN; Tavassoli FA
    Int J Gynecol Pathol; 1999 Jan; 18(1):12-9. PubMed ID: 9891237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical application of intratumoral blood flow study in patients with endometrial carcinoma.
    Cheng WF; Chen TM; Chen CA; Wu CC; Huang KT; Hsieh CY; Hsieh FJ
    Cancer; 1998 May; 82(10):1881-6. PubMed ID: 9587120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor Characteristic Variations between Symptomatic and Asymptomatic Endometrial Cancer.
    Vinklerová P; Bednaříková M; Minář L; Felsinger M; Hausnerová J; Ovesná P; Weinberger V
    Healthcare (Basel); 2021 Jul; 9(7):. PubMed ID: 34356280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The apparent diffusion coefficient (ADC) on 3-T MRI differentiates myometrial invasion depth and histological grade in patients with endometrial cancer.
    Reyes-Pérez JA; Villaseñor-Navarro Y; Jiménez de Los Santos ME; Pacheco-Bravo I; Calle-Loja M; Sollozo-Dupont I
    Acta Radiol; 2020 Sep; 61(9):1277-1286. PubMed ID: 31955608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preferential human epidermal growth factor receptor 2 expression in myometrial and lymphovascular invasion of a uterine carcinosarcoma: A case report.
    Gillam J; Pillappa R; Idowu M; Boardman C; Sullivan SA; Sayeed S
    SAGE Open Med Case Rep; 2022; 10():2050313X221081361. PubMed ID: 35273799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical significance of FIGO 2009 staging I and its prognostic related factors in endometrial carcinoma].
    Zhou J; Zhao L; Qi W; Li X; Wang J; Wei L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):776-9. PubMed ID: 25537252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.